Influence of proliferation signal inhibitors on vascular endothelial growth factor production in heart transplant recipients – preliminary report

Proliferation signal inhibitors (PSI) are especially beneficial for heart transplant recipients, but are rarely used due to frequent side effects. As they may be caused by vascular endothelial growth factor (VEGF), we performed a prospective cross-sectional pilot study to assess the influence of PSI...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamieńska, Natalia, Zakliczyński, Michał, Kasperska-Zając, Alicja, Szewczyk, Marta, Trybunia-Orzeszek, Dominika, Nożyński, Jerzy, Pijet, Marta, Hrapkowicz, Tomasz, Zembala, Marian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2014
Materias:
Heart and Lung Failure, Transplantology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283867/
https://www.ncbi.nlm.nih.gov/pubmed/26336417
http://dx.doi.org/10.5114/kitp.2014.43846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283867/
https://www.ncbi.nlm.nih.gov/pubmed/26336417
http://dx.doi.org/10.5114/kitp.2014.43846

Ejemplares similares